Teriparatide Injection
- Product: Generic
- Presentation: Pre-filled Pen / Cartridge
- Strength: 250 mcg/ml (3 ml pen = 750 mcg total dose)
We are a well-known supplier of pharmaceuticals and a global wholesaler of Teriparatide Injection, which is commonly used to treat osteoporosis in postmenopausal women and high-risk fracture-prone men. With bulk packaging, OEM/private labeling, and export-compliant documentation.
Description
Teriparatide is a recombinant human parathyroid hormone (PTH 1-34). Teriparatide is a bone-forming agent that increases bone mineral density by stimulating new bone growth. When other treatments fail, it is typically prescribed to patients with severe osteoporosis or high fracture risk. \\
Teriparatide 750 mcg injection (250 mcg/ml in 3 ml) is available from us in pre-filled pens or cartridges that can be injected subcutaneously. suitable for international buyers, pharmacies, hospitals, and tenders. Facilities that are ISO, WHO, or GMP certified are used to source the goods.
Key Product Information for Buyers & Distributors:
- Category: Osteoporosis / Bone Anabolic Agent
- Active Ingredient: Teriparatide
- Strength: 250 mcg/ml (3 ml prefilled pen = 750 mcg)
- Presentation: Prefilled injection pen or cartridge
- Administration: Subcutaneous (daily dosing)
- Packing Type: Pen with sterile needle and instructions
- MOQ: Flexible as per buyer requirement
- Labeling Options: OEM / Private Label / Neutral Packaging
- Documentation: COA, MSDS, Stability Data, Export Dossier
We supply Teriparatide Injections to government contracts, hospital chains, international tenders, and global distributors across Africa, Asia, and the Middle East.
Q1. What is the purpose of Teriparatide Injection?
A: It is used to treat osteoporosis in men and postmenopausal women who are at high risk for bone fractures, as well as in patients who are unable to tolerate or respond to other treatments for osteoporosis.
Q2. How is Teriparatide given?
A: Teriparatide is given subcutaneously once a day with a prefilled injection pen or cartridge.
Q3. What is the usual strength and dosage available?
A: Standard presentation is 750 mcg (250 mcg/ml in 3 ml) per pen or cartridge.
Q4. Do you offer OEM or private labeling?
A: Yes. We do OEM/private label packaging, including neutral branding for export and custom branding for partners.
Q5. Are your Teriparatide injection export-ready?
A: Yes. We supply products with full export documentation, sourced from certified WHO-GMP/GMP/ISO facilities.
You may also be interested in Imipenem+Cilastatin Injection – a powerful option for resistant infections.
